Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Michael I. Treshchalin"'
Autor:
Michael I. Treshchalin, Vasilisa A. Polozkova, Elena I. Moiseenko, Andrey E. Shchekotikhin, Svetlana A. Dovzhenko, Mikhail B. Kobrin, Eleonora R. Pereverzeva
Publikováno v:
Pharmaceuticals, Vol 16, Iss 11, p 1569 (2023)
Glycopeptide antibiotics are still in demand in clinical practice for treating infections caused by resistant gram-positive pathogens; however, their use is limited due to severe adverse reactions. Their predominant types of side effects are immunogl
Externí odkaz:
https://doaj.org/article/0dab87cac10848d88f5e48f6cad1f307
Autor:
Michael I. Treshchalin, Vasilisa A. Polozkova, Elena I. Moiseenko, Helen M. Treshalina, Andrey E. Shchekotikhin, Eleonora R. Pereverzeva
Publikováno v:
Pharmaceuticals, Vol 15, Iss 6, p 661 (2022)
Glycopeptide antibiotics have side effects that limit their clinical use. In view of this, the development of glycopeptides with improved chemotherapeutic properties remains the main direction in the search for new antibacterial drugs. The objective
Externí odkaz:
https://doaj.org/article/9e76961421c2480197b4a2dee2f6aa2a
Autor:
Alexey S. Trenin, Elena B. Isakova, Michael I. Treshchalin, Vasilisa A. Polozkova, Elena P. Mirchink, Alexey A. Panov, Alexander Y. Simonov, Olga P. Bychkova, Victor V. Tatarskiy, Sergey N. Lavrenov
Publikováno v:
Pharmaceuticals, Vol 15, Iss 2, p 118 (2022)
The antimicrobial activity and toxicity of three novel synthetic antibacterial agents containing tris(1H-indol-3-yl)methylium fragment were studied in vitro and in vivo. All compounds in vitro revealed high activity (minimal inhibitory concentration
Externí odkaz:
https://doaj.org/article/bca3f521e64443ccbe39cf083d78031c
Autor:
Michael I. Treshchalin, Helen M. Treshalina, Vasilisa A. Golibrodo, Andrey E. Shchekotikhin, Eleonora R. Pereverzeva
Publikováno v:
Pharmaceuticals, Vol 14, Iss 9, p 900 (2021)
A new antitumor multi-target drug anthrafuran, with cellular targets such as topoisomerase I/II and some protein kinases, was obtained in Gause Institute of New Antibiotics and was demonstrated to have a reliable specific effect on different murine a
Externí odkaz:
https://doaj.org/article/f182aab59ec64f80b0016e80105d04fe
Autor:
Andrey E. Shchekotikhin, Helen M. Treshalina, Michael I. Treshchalin, Eleonora R. Pereverzeva, Helen B. Isakova, Alexander S. Tikhomirov
Publikováno v:
Pharmaceuticals, Vol 13, Iss 5, p 81 (2020)
The new antitumor agent anthrafuran has demonstrated a consistent effect in murine tumor models when administered parenterally due to the simultaneous inhibition of multiple cellular targets such as topoisomerases I/II and protein kinases. In this st
Externí odkaz:
https://doaj.org/article/79394834a2f94ec88b9644771f8122fa
Autor:
Alexey S, Trenin, Elena B, Isakova, Michael I, Treshchalin, Vasilisa A, Polozkova, Elena P, Mirchink, Alexey A, Panov, Alexander Y, Simonov, Olga P, Bychkova, Victor V, Tatarskiy, Sergey N, Lavrenov
Publikováno v:
Pharmaceuticals (Basel, Switzerland). 15(2)
The antimicrobial activity and toxicity of three novel synthetic antibacterial agents containing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e5052a5771738042723ac4c5748b60db
https://pubmed.ncbi.nlm.nih.gov/35215231
https://pubmed.ncbi.nlm.nih.gov/35215231